Recombinant antibody production utilizes Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex biologics. Optimizing these processes involves adjusting various parameters, including cell line engineering, media ingredients, and bioreactor settings. A key goal is to amplify antibody titer while lowering production financial